News
European drug agency backtracks on plan to give researchers access to clinical trial reports
BMJ 2014; 348 doi: https://doi.org/10.1136/bmj.g3432 (Published 21 May 2014) Cite this as: BMJ 2014;348:g3432
Related articles
- News Published: 03 April 2014; BMJ 348 doi:10.1136/bmj.g2579
- News Published: 07 April 2014; BMJ 348 doi:10.1136/bmj.g2632
- Research Published: 09 April 2014; BMJ 348 doi:10.1136/bmj.g2545
- News Published: 02 May 2013; BMJ 346 doi:10.1136/bmj.f2846
- News Published: 26 November 2012; BMJ 345 doi:10.1136/bmj.e8061
- Editorial Published: 28 May 2014; BMJ 348 doi:10.1136/bmj.g3561
- News Published: 05 June 2014; BMJ 348 doi:10.1136/bmj.g3733
- News Published: 12 June 2014; BMJ 348 doi:10.1136/bmj.g3852
See more
- How bibliometrics and school rankings reward unreliable scienceBMJ August 17, 2023, 382 p1887; DOI: https://doi.org/10.1136/bmj.p1887
- Unveiling hidden inequalities in diversity and inclusion in medical researchBMJ June 13, 2023, 381 p1354; DOI: https://doi.org/10.1136/bmj.p1354
- Give doctors financial incentives to take part in clinical trials, review recommendsBMJ May 30, 2023, 381 p1226; DOI: https://doi.org/10.1136/bmj.p1226
- How pandemic publishing struck a blow to the visibility of women’s expertiseBMJ April 06, 2023, 381 p788; DOI: https://doi.org/10.1136/bmj.p788
- How covid-19 bolstered an already perverse publishing systemBMJ March 28, 2023, 380 p689; DOI: https://doi.org/10.1136/bmj.p689
Cited by...
- Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN (Overcome failure to Publish nEgative fiNdings) project based on an international consensus meeting
- European Medicines Agency pledges to publish clinical reports
- EMA policy on transparency is "strikingly" similar to deal struck with drug company, say experts
- European Ombudsman ramps up action against European Medicines Agency over data transparency plans
- Redacted policy on sharing drug trial data in Europe